Insulet (PODD) Interest & Investment Income (2010 - 2026)
Insulet (PODD) posted Interest & Investment Income of $4.9 million for Q1 2026, down 14.04% on a QoQ basis from $5.7 million in Q4 2025, and down 52.43% year-over-year from $10.3 million in Q1 2025.
Insulet (PODD) Interest & Investment Income (2010 - 2026) Analysis & Trends
Insulet's Interest & Investment Income history runs 11 years deep, the most recent figure standing at $4.9 million for Q1 2026.
- Quarterly Interest & Investment Income fell 52.43% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.3 million (down 27.48% YoY) and the FY2025 annual result came in at $34.7 million, down 12.15% from the prior year.
- Interest & Investment Income was $4.9 million for Q1 2026 at Insulet, down from $5.7 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $10.5 million in Q3 2024 and bottomed at $2.4 million in Q3 2022.
- A 5-year average of $7.7 million and a median of $8.6 million in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income jumped 258.33% — and 2026, when it tumbled 52.43%.
- Insulet's Interest & Investment Income stood at $6.0 million in 2022, then grew by 3.33% to $6.2 million in 2023, then jumped by 66.13% to $10.3 million in 2024, then tumbled by 44.66% to $5.7 million in 2025, then dropped by 14.04% to $4.9 million in 2026.
- Business Quant data shows PODD's Interest & Investment Income at $4.9 million in Q1 2026, $5.7 million in Q4 2025, and $8.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Insulet | 11.52 Bn | 11.04 Bn | 529.10 Mn | 4.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.90 Mn |
| Dec 31, 2025 | 5.70 Mn |
| Sep 30, 2025 | 8.60 Mn |
| Jun 30, 2025 | 10.10 Mn |
| Mar 31, 2025 | 10.30 Mn |
| Dec 31, 2024 | 10.30 Mn |
| Sep 30, 2024 | 10.50 Mn |
| Jun 30, 2024 | 9.30 Mn |
| Mar 31, 2024 | 9.40 Mn |
| Dec 31, 2023 | 6.20 Mn |
| Sep 30, 2023 | 8.60 Mn |
| Jun 30, 2023 | 7.30 Mn |
| Mar 31, 2023 | 6.50 Mn |
| Dec 31, 2022 | 6.00 Mn |
| Sep 30, 2022 | 2.40 Mn |
| Sep 30, 2015 | 46,000.00 |
| Jun 30, 2015 | 41,000.00 |
| Mar 31, 2015 | 36,000.00 |
| Dec 31, 2014 | 37,000.00 |
| Sep 30, 2014 | 32,000.00 |